Mutual Funds
Nippon India Pharma Fund(G)
Equity  |   Very High  |   Equity - Sectoral Fund - Pharma & Health Care
564.84   +0.62
NAV(₹) as on 6/7/2026 		0.11%
  1D 		8.05%
  1Y 		20.86%
  3Y 		12.92%
  5Y
Nippon India Pharma Fund(G)
Growth Chart of the Scheme

Scheme Details
Expense Ratio:
1.78 		Launch Date:
05 Jun 2004
Exit Load:
1% on or before 1M, Nil after 1M 		AUM:
₹ 8,635.75 Crs
Lock-in:
Nil 		Investing Style:
Large Growth
Portfolio Price To Book Value:
7.39 		Min. Investment:
SIP : ₹ 100.00
Lumpsum : ₹ 5,000.00
Scheme Benchmark:
NA
Fund Manager:
Sailesh Raj Bhan

FUND OBJECTIVE

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

LATEST ASSET & PORTFOLIO ALLOCATION Others Equity
as on 31/5/2026 2.08 % 97.92 %
TOP HOLDINGS

Sun Pharmaceutical Industries Ltd.
13.35 %

Lupin Ltd.
7.31 %

Dr. Reddy's Laboratories Ltd.
6.72 %

Cipla Ltd.
6.16 %

Divi's Laboratories Ltd.
5.80 %

Apollo Hospitals Enterprise Ltd.
5.20 %

Mankind Pharma Ltd.
3.94 %

Medplus Health Services Ltd.
3.68 %

Sai Life Sciences Ltd.
3.43 %

Ajanta Pharma Ltd.
3.21 %

See All Holding
ALLOCATION BY MARKET CAP (Equity)
ALLOCATION BY RATING (Debt & Others)

No Data

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs
72.34 %

Hospital & Healthcare Servic
20.11 %

Retailing
3.68 %

Business Support
1.79 %

See All Sectors
PORTFOLIO CHARACTERISTICS (Debt)

No Data

5 YEAR HISTORY

Financial Year 2021-22 2022-23 2023-24 2024-25 2025-26
NAV (31/3/2026) 290.14 270.59 428.87 481.27 489.71
Net Assets (Rs Crores) 4,93,188.52 4,30,446.45 7,12,528.46 8,08,096.99 7,89,824.17
Scheme Returns(%)(Absolute) 14.83 -6.85 58.24 10.94 3.30
B'mark Returns(%)(Absolute) NA NA NA NA NA
Category Rank 43/75 65/76 17/90 30/102 25/120
RISKOMETER
Level of Risk in the Scheme

Clients will understand that their principal will be at Very High risk.

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Fund Details Inception Date Aum(₹ Crs) 1Y 3Y 5Y Since Inception
MDB Logo
Kotak Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  16.16   +0.16  
11/12/2023 ₹ 560.17 19.15% - - 20.60%
MDB Logo
Quant Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  17.36   +0.03  
17/7/2023 ₹ 372.5 8.93% - - 20.40%
MDB Logo
HDFC Pharma and Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  20.70   +-0.02  
4/10/2023 ₹ 2,362.44 20.98% - - 30.37%
MDB Logo
WOC Pharma and Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  16.15   +-0.06  
6/2/2024 ₹ 664.02 17.98% - - 21.95%
MDB Logo
PGIM India Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  11.43   +0.09  
6/12/2024 ₹ 95.49 14.53% - - 8.87%
MDB Logo
Bajaj Finserv Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  11.05   +0.03  
27/12/2024 ₹ 332.52 13.06% - - 6.75%
MDB Logo
Baroda BNP Paribas Health and Wellness Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  10.49   +0.04  
27/6/2025 ₹ 544.17 4.28% - - 4.80%
MDB Logo
Bandhan Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  10.87   +0.13  
28/11/2025 ₹ 310.92 - - - 8.66%
MDB Logo
ITI Pharma & Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  17.63   +0.01  
8/11/2021 ₹ 237.99 5.63% 19.38% - 12.94%
MDB Logo
Nippon India Pharma Fund(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  564.84   +0.62  
5/6/2004 ₹ 8,635.75 8.05% 20.86% 12.92% 20.03%